


Protein Alternatives SL (PROALT) Revenue
Biotechnology Research • Tres Cantos, Community of Madrid, Spain • 1-10 Employees
Protein Alternatives SL (PROALT) revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $2,600,000 |
Key Contact at Protein Alternatives SL (PROALT)
Juan Ignacio Imbaud
Chief Executive Officer
Company overview
| Headquarters | Ronda de Poniente 16, 1º A-F, Tres Cantos, Madrid 28760, ES |
| Phone number | +34918047322 |
| Website | |
| SIC | 873 |
| Keywords | Biotechnology, Biomarkers, Contract Research Services, Diagnostic Kits, Cancer Diagnostic, Recombinant Proteins And Antibodies |
| Founded | 2006 |
| Employees | 1-10 |
| Socials |
Protein Alternatives SL (PROALT) Email Formats
Protein Alternatives SL (PROALT) uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@proteinalternatives.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@proteinalternatives.com | 50% |
{first name}{last name} | johndoe@proteinalternatives.com | 50% |
About Protein Alternatives SL (PROALT)
Protein Alternatives SL (ProAlt) is a biotechnology company founded in 2006 and headquartered in Madrid, Spain. ProAlt’s mission is the development and commercialization of biomarker-based assays for early cancer diagnosis and the development of therapeutic monoclonal antibodies for the treatment of metastatic cancers. ProAlt’s main priority is the development of a test for screening and early diagnosis of colorectal cancer in population at risk, requiring only a conventional blood extraction. This product should offer significant advantages over current diagnostic tools, offering a considerable higher detection capacity, simple usage and a reduced cost when compared with high complexity technologies like colonoscopy, an invasive test with potential relevant side effects. The company strength is a deep knowledge of protein and antibody design, development and production. In this sense, ProAlt’s additional goal is to offer different products and custom-tailored services, mainly related to proteins and antibodies production and/or protein expression, to meet the needs of the academic and biotechnology industry. The company offers own-manufactured innovative proteins and antibodies, some of them exclusively provided by ProAlt, and specialized services in protein design and production based on three different expression systems: E. coli (bacterial), Baculovirus in insect cells and mammalian cells. For more information: http://www.proteinalternatives.com
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Protein Alternatives SL (PROALT) has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Explore Protein Alternatives SL (PROALT)'s funding history, including investment rounds, total capital raised, and key backers.
Protein Alternatives SL (PROALT) Tech Stack
Discover the technologies and tools that power Protein Alternatives SL (PROALT)'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Miscellaneous
JavaScript libraries
UI frameworks
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Security
Frequently asked questions
4.8
40,000 users



